Modern Technologies in Diagnosis of Fungal Keratitis (Review)

Traumas and infectious diseases of the eye play a leading role in the development of corneal blindness responsible for 1.5–2 million cases of vision loss per year. To date, the issue of reducing the incidence of fungal keratitis is acute and needs to be solved worldwide. Trauma as a risk factor for corneal fungal disease is thought to be prevalent in developing countries due to agricultural involvement, while in developed countries the onset of the disease is predisposed by medical advances such as contact vision correction and modern ophthalmic surgery. Thorough analysis of the pathogenesis gives the possibility to describe the action of fungal enzymes, biofilm formation, and the resistance mechanism, which on the one hand explains the aggressive course of the disease and difficulties in its diagnosis, and on the other hand, it encourages searching for new methods of diagnosis and treatment. The non-specific clinical picture of fungal keratitis, the variety and availability of antibiotics nowadays become an obstacle for rapid detection of this pathology. Low public awareness and late visit to an ophthalmologist are also a barrier to successful combating the increasing incidence of fungal keratitis. Belated diagnosis, increasing resistance of fungi to antibiotics, and lack of registered antifungal ophthalmic drugs justify poor treatment efficacy resulting in decreased visual acuity or vision loss.

Existing diagnostic methods need systematization and detailed comparison, identifying the advantages and disadvantages of each. This review considers causative agents and their influence on pathogenesis of the disease, describes difficulties of fungal keratitis diagnosis and possible ways of overcoming these problems using new developments, and also outlines further prospects of research in this direction.

1. Mayansky A.N. Patogeneticheskaya mikrobiologiya [Pathogenetic microbiology]. Nizhny Novgorod: Izdatel’stvo NizhGMA; 2006; 520 p.
2. Mencl K. Medical mycology — the Cinderella of the microbiology family. Klin Mikrobiol Infekc Lek 2007; 13(4): 135.
3. Vallabhaneni S., Mody R.K., Walker T., Chiller T. The global burden of fungal diseases. Infect Dis Clin North Am 2016; 30(1): 1–11, https://doi.org/10.1016/j.idc.2015.10.004.
4. Benedict K., Jackson B.R., Chiller T., Beer K.D. Estimation of direct healthcare costs of fungal diseases in the United States. Clin Infect Dis 2019; 68(11): 1791–1797, https://doi.org/10.1093/cid/ciy776.
5. Lin I.H., Chang Y.S., Tseng S.H., Huang Y.H. A comparative, retrospective, observational study of the clinical and microbiological profiles of post-penetrating keratoplasty keratitis. Sci Rep 2016; 6: 32751, https://doi.org/10.1038/srep32751.
6. Bograd A., Seiler T., Droz S., Zimmerli S., Früh B., Tappeiner C. Bacterial and fungal keratitis: a retrospective analysis at a university hospital in Switzerland. Klin Monatsbl Augenheilkd 2019; 236(4): 358–365, https://doi.org/10.1055/a-0774-7756.
7. Bongomin F., Gago S., Oladele R., Denning D. Global and multi-national prevalence of fungal diseases — estimate precision. J Fungi (Basel) 2017; 3(4): 57, https://doi.org/10.3390/jof3040057.
8. Brown L., Leck A.K., Gichangi M., Burton M.J., Denning D.W. The global incidence and diagnosis of fungal keratitis. Lancet Infect Dis 2021; 21(3): e49–e57, https://doi.org/10.1016/s1473-3099(20)30448-5.
9. Gupta N., Tandon R., Gupta S.K., Sreenivas V., Vashist P. Burden of corneal blindness in India. Indian J Community Med 2013; 38(4): 198–206, https://doi.org/10.4103/0970-0218.120153.
10. Ahmadikia K., Aghaei Gharehbolagh S., Fallah B., Naeimi Eshkaleti M., Malekifar P., Rahsepar S., Getso M.I., Sharma S., Mahmoudi S. Distribution, prevalence, and causative agents of fungal keratitis: a systematic review and meta-analysis (1990 to 2020). Front Cell Infect Microbiol 2021; 11: 698780, https://doi.org/10.3389/fcimb.2021.698780.
11. Dahlgren M.A., Lingappan A., Wilhelmus K.R. The clinical diagnosis of microbial keratitis. Am J Ophthalmol 2007; 143(6): 940–944.e1, https://doi.org/10.1016/j.ajo.2007.02.030.
12. Wong T.Y., Ng T.P., Fong K.S., Tan D.T. Risk factors and clinical outcomes between fungal and bacterial keratitis: a comparative study. CLAO J 1997; 23(4): 275–281.
13. Ali Shah S.I., Shah S.A., Rai P., Katpar N.A., Abbasi S.A., Soomro A.A. Visual outcome in patients of keratomycosis, at a tertiary care centre in Larkana, Pakistan. J Pak Med Assoc 2017; 67(7): 1035–1038.
14. Obrubov A.S., Slonimskii A.Yu. Contact lens-related keratitis and purulent corneal ulcers. Vestnik oftalmologii 2018; 134(4): 17–24, https://doi.org/10.17116/oftalma201813404117.
15. Zhu Z., Zhang H., Yue J., Liu S., Li Z., Wang L. Antimicrobial efficacy of corneal cross-linking in vitro and in vivo for Fusarium solani: a potential new treatment for fungal keratitis. BMC Ophthalmol 2018; 18(1): 65, https://doi.org/10.1186/s12886-018-0727-0.
16. Wang Y., Chen H., Xia T., Huang Y. Characterization of fungal microbiota on normal ocular surface of humans. Clin Microbiol Infect 2020; 26(1): 123.e9–123.e13, https://doi.org/10.1016/j.cmi.2019.05.011.
17. Belskaia K.I., Obrubov A.S. Pathogenesis and clinical features of fungal keratitis (review). Oftal’mologia 2021; 18(1): 12–19, https://doi.org/10.18008/1816-5095-2021-1-12-19.
18. Svetozarskiy S.N., Andreev A.N., Scherbakova S.V., Smetankin I.G. Successful treatment of fungal keratitis after penetrating keratoplasty. Meditsinskiy vestnik Bashkortostana 2020; 15(4): 17–20.
19. Khater M.M., Shehab N.S., El-Badry A.S. Comparison of mycotic keratitis with nonmycotic keratitis: an epidemiological study. J Ophthalmol 2014; 2014: 254302, https://doi.org/10.1155/2014/254302.
20. Skryabina Y.V., Astakhov Y.S., Konenkova Y.S., Kasymov F.O., Zumbulidze N.G., Varganova T.S., Petukhov V.P., Pirgunova A.A., Masian J., Klimko N.N., Bogomolova T.S., Desyatik E.A. Diagnosis and treatment of fungal keratitis. Part I. Oftal’mologiceskie vedomosti 2018; 11(3): 63–73, https://doi.org/10.17816/ov11363-73.
21. Rohilla R., Meena S., Mohanty A., Gupta N., Kaistha N., Gupta P., Mangla A., Singh A. Etiological spectrum of infectious keratitis in the era of MALDI-TOF-MS at a tertiary care hospital. J Family Med Prim Care 2020; 9(9): 4576–4581, https://doi.org/10.4103/jfmpc.jfmpc_630_20.
22. Ting D.S.J., Galal M., Kulkarni B., Elalfy M.S., Lake D., Hamada S., Said D.G., Dua H.S. Clinical characteristics and outcomes of fungal keratitis in the United Kingdom 2011–2020: a 10-year study. J Fungi (Basel) 2021; 7(11): 966, https://doi.org/10.3390/jof7110966.
23. Watson S.L., Cabrera-Aguas M., Keay L., Khoo P., McCall D., Lahra M.M. The clinical and microbiological features and outcomes of fungal keratitis over 9 years in Sydney, Australia. Mycoses 2020; 63(1): 43–51, https://doi.org/10.1111/myc.13009.
24. Sharma S., Singh S., Goel S., Farooq U. Role of biofilms in fungal keratitis — an overview. J Bacteriol Mycol Open Access 2017; 5(6): 409–412, https://doi.org/10.15406/jbmoa.2017.05.00157.
25. Astakhov Y.S., Skryabina Y.V., Konenkova Y.S., Kasymov F.O., Bogomolova T.S., Pinegina O.N. Mycotic keratitis diagnosis and treatment. Oftal’mologiceskie vedomosti 2013; 6(2): 75–80, https://doi.org/10.17816/ov2013275-80.
26. Imamura Y., Chandra J., Mukherjee P.K., Lattif A.A., Szczotka-Flynn L.B., Pearlman E., Lass J.H., O’Donnell K., Ghannoum M.A. Fusarium and Candida albicans biofilms on soft contact lenses: model development, influence of lens type, and susceptibility to lens care solutions. Antimicrob Agents Chemother 2008; 52(1): 171–182, https://doi.org/10.1128/aac.00387-07.
27. Zakirova G.Z. Fungal keratitis associated with the use of contact lenses (clinical case). Vestnik oftalmologii 2021; 137(1): 74–77, https://doi.org/10.17116/oftalma202113701174.
28. Svetozarskiy S.N., Andreev A.N., Shcherbakova S.V. Fungal keratitis after penetrating keratoplasty. Vestnik oftalmologii 2019; 135(4): 98–102, https://doi.org/10.17116/oftalma201913504198.
29. Poltanova T.I., Belousova N.Y. Recurrence of fungal keratitis in corneal transplant. Kazanskij medicinskij zurnal 2018; 99(1): 148–150, https://doi.org/10.17816/kmj2018-148.
30. Fontana L., Moramarco A., Mandarà E., Russello G., Iovieno A. Interface infectious keratitis after anterior and posterior lamellar keratoplasty. Clinical features and treatment strategies. A review. Br J Ophthalmol 2019; 103(3): 307–314, https://doi.org/10.1136/bjophthalmol-2018-312938.
31. Gupta G., Feder R.S., Lyon A.T. Fungal keratitis with intracameral extension following penetrating keratoplasty. Cornea 2009; 28(8): 930–932, https://doi.org/10.1097/ico.0b013e31819b3213.
32. Augustin V.A., Weller J.M., Kruse F.E., Tourtas T. Fungal interface keratitis after Descemet membrane endothelial keratoplasty. Cornea 2018; 37(11): 1366–1369, https://doi.org/10.1097/ico.0000000000001727.
33. Vaidya N.S., Epstein R.H., Majmudar P.A. Fungal infectious interface keratitis presenting 2 years after Descemet membrane endothelial keratoplasty. Cornea 2022; 41(7): 917–920, https://doi.org/10.1097/ico.0000000000002892.
34. Ghaffari R., Bonnet C., Yung M., Bostan C., Harissi-Dagher M., Aldave A.J. Infectious keratitis after Boston type 1 keratoprosthesis implantation. Cornea 2021; 40(10): 1298–1308, https://doi.org/10.1097/ico.0000000000002649.
35. Soleimani M., Haydar A.A. Fungal keratitis after small incision lenticule extraction (SMILE): a case report and review of the literature. J Ophthal Inflamm Infect 2021; 11(1): 25, https://doi.org/10.1186/s12348-021-00256-0.
36. Kamilov H.M., Abdullaev Sh.R., Kasymova M.S. Clinical Features of posttraumatic fungal bacterial keratitis ulcer. Vìsnik problem biologii i medicini 2012; 1(3): 59–62.
37. Subudhi P., Patro S., Pattanayak S., Agarwal P., Sitaram S., Subudhi B.N.R. Toxic non-inflammatory fungal keratitis. Indian J Ophthalmol 2022; 70(5): 1578–1581, https://doi.org/10.4103/ijo.IJO_2509_21.
38. Mills B., Radhakrishnan N., Karthikeyan Rajapandian S.G., Rameshkumar G., Lalitha P., Prajna N.V. The role of fungi in fungal keratitis. Exp Eye Res 2021; 202: 108372, https://doi.org/10.1016/j.exer.2020.108372.
39. Cheng M., Lin J., Li C., Zhao W., Yang H., Lv L., Che C. Wedelolactone suppresses IL-1β maturation and neutrophil infiltration in Aspergillus fumigatus keratitis. Int Immunopharmacol 2019; 73: 17–22, https://doi.org/10.1016/j.intimp.2019.04.050.
40. Gu L., Lin J., Wang Q., Li C., Peng X., Fan Y., Lu C., Lin H., Niu Y., Zhu G., Zhao G. Dimethyl itaconate protects against fungal keratitis by activating the Nrf2/HO-1 signaling pathway. Immunol Cell Biol 2020; 98(3): 229–241, https://doi.org/10.1111/imcb.12316.
41. Liu Y., Li J., Liu Y., Wang P., Jia H. Inhibition of zymosan-induced cytokine and chemokine expression in human corneal fibroblasts by triptolide. Int J Ophthalmol 2016; 9(1): 9–14, https://doi.org/10.18240/ijo.2016.01.02.
42. Sudan R., Sharma Y.R. Keratomycosis: clinical diagnosis, medical and surgical treatment. JK Science 2003; 5(1): 3–10.
43. Ballal S., Belur S., Laha P., Roy S., Swamy B.M., Inamdar S.R. Mitogenic lectins from Cephalosporium curvulum (CSL) and Aspergillus oryzae (AOL) mediate host–pathogen interactions leading to mycotic keratitis. Mol Cell Biochem 2017; 434(1–2): 209–219, https://doi.org/10.1007/s11010-017-3050-9.
44. de Vries O.M.H., Fekkes M.P., Wösten H.A.B., Wessels J.G.H. Insoluble hydrophobin complexes in the walls of Schizophyllum commune and other filamentous fungi. Arch Microbiol 1993; 159(4): 330–335, https://doi.org/10.1007/bf00290915.
45. Zhang X., Sun X., Wang Z., Zhang Y., Hou W. Keratitis-associated fungi form biofilms with reduced antifungal drug susceptibility. Invest Ophthalmol Vis Sci 2012; 53(12): 7774–7778, https://doi.org/10.1167/iovs.12-10810.
46. Calvillo-Medina R.P., Martínez-Neria M., Mena-Portales J., Barba-Escoto L., Raymundo T., Campos-Guillén J., Jones G.H., Reyes-Grajeda J.P., González-Y-Merchand J.A., Bautista-de Lucio V.M. Identification and biofilm development by a new fungal keratitis aetiologic agent. Mycoses 2019; 62(1): 62–72, https://doi.org/10.1111/myc.12849.
47. Chebotar’ I.V. Mechanisms of antibiofilm immunity. Vestnik Rossiiskoi akademii meditsinskikh nauk 2012; 67(12): 22–29, https://doi.org/10.15690/vramn.v67i12.477.
48. Fanning S., Mitchell A.P. Fungal biofilms. PLoS Pathog 2012; 8(4): e1002585, https://doi.org/10.1371/journal.ppat.1002585.
49. Delattin N., Cammue B.P.A., Thevissen K. Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms. Future Med Chem 2014; 6(1): 77–90, https://doi.org/10.4155/fmc.13.189.
50. Elder M.J., Matheson M., Stapleton F., Dart J.K. Biofilm formation in infectious crystalline keratopathy due to Candida albicans. Cornea 1996; 15(3): 301–304, https://doi.org/10.1097/00003226-199605000-00012.
51. Dolgushin I.I., Mezentseva E.A. Neutrophil extracellular traps in the fight against biofilm-forming microorganisms: hunters or prey? Zhurnal mikrobiologii epidemiologii i immunobiologii 2020; 97(5): 468–481, https://doi.org/10.36233/0372-9311-2020-97-5-9.
52. Valieva R.I., Lisovskaya S.A., Mayanskaya K.A., Samigullin D.V., Isaeva G.S. Features of antifungal therapy during long-lasting infectious process: a clinical case of fungal keratitis and profile of antifungal sensitivity based on assessing biofilm formation. Infekcia i immunitet 2021; 11(4): 789–797, https://doi.org/10.15789/2220-7619-foa-1495.
53. Vemuganti G.K., Garg P., Gopinathan U., Naduvilath T.J., John R.K., Buddi R., Rao G.N. Evaluation of agent and host factors in progression of mycotic keratitis. Ophthalmology 2002; 109(8): 1538–1546, https://doi.org/10.1016/s0161-6420(02)01088-6.
54. Niu L., Liu X., Ma Z., Yin Y., Sun L., Yang L., Zheng Y. Fungal keratitis: pathogenesis, diagnosis and prevention. Microb Pathog 2020; 138: 103802, https://doi.org/10.1016/j.micpath.2019.103802.
55. Leal S.M. Jr., Vareechon C., Cowden S., Cobb B.A., Latgé J.P., Momany M., Pearlman E. Fungal antioxidant pathways promote survival against neutrophils during infection. J Clin Invest 2012; 122(7): 2482–2498, https://doi.org/10.1172/jci63239.
56. Gao X., Zhao G., Li C., Lin J., Jiang N., Wang Q., Hu L., Xu Q., Peng X., He K., Zhu G. LOX-1 and TLR4 affect each other and regulate the generation of ROS in A. fumigatus keratitis. Int Immunopharmacol 2016; 40: 392–399, https://doi.org/10.1016/j.intimp.2016.09.027.
57. Li C., Li C., Lin J., Zhao G., Xu Q., Jiang N., Wang Q., Peng X., Zhu G., Jiang J. The role of autophagy in the innate immune response to fungal keratitis caused by Aspergillus fumigatus infection. Invest Ophthalmol Vis Sci 2020; 61(2): 25, https://doi.org/10.1167/iovs.61.2.25.
58. Kanayama M., Inoue M., Danzaki K., Hammer G., He Y.W., Shinohara M.L. Autophagy enhances NFκB activity in specific tissue macrophages by sequestering A20 to boost antifungal immunity. Nat Commun 2015; 6: 5779, https://doi.org/10.1038/ncomms6779.
59. Xie L., Zhai H., Shi W., Zhao J., Sun S., Zang X. Hyphal growth patterns and recurrence of fungal keratitis after lamellar keratoplasty. Ophthalmology 2008; 115(6): 983–987, https://doi.org/10.1016/j.ophtha.2007.07.034.
60. Xie L., Zhong W., Shi W., Sun S. Spectrum of fungal keratitis in north China. Ophthalmology 2006; 113(11): 1943–1948, https://doi.org/10.1016/j.ophtha.2006.05.035.
61. Niewerth M., Korting H.C. Phospholipases of Candida albicans. Mycoses 2001; 44(9–10): 361–367, https://doi.org/10.1046/j.1439-0507.2001.00685.x.
62. Monte F.Q., Stadtherr N.M. Reflections on mycotic keratitis based on findings from histopathologically examined specimens. Rev Bras Oftalmol 2013; 72(2): 87–94, https://doi.org/10.1590/s0034-72802013000200003.
63. Weissgold D.J., Orlin S.E., Sulewski M.E., Frayer W.C., Eagle R.C. Jr. Delayed-onset fungal keratitis after endophthalmitis. Ophthalmology 1998; 105(2): 258–262, https://doi.org/10.1016/s0161-6420(98)92938-4.
64. Thomas P.A., Leck A.K., Myatt M. Characteristic clinical features as an aid to the diagnosis of suppurative keratitis caused by filamentous fungi. Br J Ophthalmol 2005; 89(12): 1554–1558, https://doi.org/10.1136/bjo.2005.076315.
65. Kovaleva L.A., Krichevskaya G.I., Maкarov P.V., Petrova A.O., Flora S.V., Zyurnyayeva I.D., Andryushin A.E., Markelova O.I. Fungal corneal ulcer complicated by endophthalmitis: clinical and laboratory diagnostics, treatment tactics. Rossijskij oftal’mologiceskij zurnal 2022; 15(1): 19–24, https://doi.org/10.21516/2072-0076-2022-15-1-19-24.
66. Dalmon C., Porco T.C., Lietman T.M., Prajna N.V., Prajna L., Das M.R., Kumar J.A., Mascarenhas J., Margolis T.P., Whitcher J.P., Jeng B.H., Keenan J.D., Chan M.F., McLeod S.D., Acharya N.R. The clinical differentiation of bacterial and fungal keratitis: a photographic survey. Investig Opthalmol Vis Sci 2012; 53(4): 1787–1791, https://doi.org/10.1167/iovs.11-8478.
67. Burton M.J., Pithuwa J., Okello E., Afwamba I., Onyango J.J., Oates F., Chevallier C., Hall A.B. Microbial keratitis in East Africa: why are the outcomes so poor? Ophthalmic Epidemiol 2011; 18(4): 158–163, https://doi.org/10.3109/09286586.2011.595041.
68. Botabekova T.K., Suleimenov M.S., Isergepova B.I. Clinic details and retina mycotic lesion treatment. Tocka zrenia. Vostok-Zapad 2016; 1: 133–136.
69. Parmar D.P., Rathod J.S., Karkhanawala M.M., Bhole P.K., Rathod D.S. Foldscope: a smartphone based diagnostic tool for fungal keratitis. Indian J Ophthalmol 2021; 69(10): 2836–2840, https://doi.org/10.4103/ijo.ijo_3331_20.
70. Maychuk D.Y., Tarkhanova A.A., Loshkareva A.O., Drozdkov I.A. Determination of the leading clinical findings of fungal keratitis based on the experience of patient management with the provision of a clinical case. Sovremennye tehnologii v oftal’mologii 2021; 4: 21–24, https://doi.org/10.25276/2312-4911-2021-4-21-24.
71. Prajna V.N., Prajna L., Muthiah S. Fungal keratitis: the aravind experience. Indian J Ophthalmol 2017; 65(10): 912–919, https://doi.org/10.4103/ijo.IJO_821_17.
72. Bourcier T., Sauer A., Dory A., Denis J., Sabou M. Fungal keratitis. J Fr Ophtalmol 2017; 40(9): e307–e313, https://doi.org/10.1016/j.jfo.2017.08.001.
73. Jin X., Jin H., Shi Y., Zhang N., Zhang H. Clinical observation of corneal endothelial plaques with fungal and bacterial keratitis by anterior segment optical coherence tomography and in vivo confocal microscopy. Cornea 2022; 41(11): 1426–1432, https://doi.org/10.1097/ico.0000000000002912.
74. Chidambaram J.D., Venkatesh Prajna N., Srikanthi P., Lanjewar S., Shah M., Elakkiya S., Lalitha P., Burton M.J. Epidemiology, risk factors, and clinical outcomes in severe microbial keratitis in South India. Ophthalmic Epidemiol 2018; 25(4): 297–305, https://doi.org/10.1080/09286586.2018.1454964.
75. Malhotra S., Sharma S., Kaur N., Hans C. Fungal keratitis — a brief overview. J Ophthalmic Clin Res 2015; 2(3): 18–22, https://doi.org/10.24966/ocr-8887/100018.
76. Wallang B.S., Das S., Sharma S., Sahu S.K., Mittal R. Ring infiltrate in staphylococcal keratitis. J Clin Microbiol 2013; 51(1): 354–355, https://doi.org/10.1128/jcm.02191-12.
77. Mascarenhas J., Lalitha P., Prajna N.V., Srinivasan M., Das M., D’Silva S.S., Oldenburg C.E., Borkar D.S., Esterberg E.J., Lietman T.M., Keenan J.D. Acanthamoeba, fungal, and bacterial keratitis: a comparison of risk factors and clinical features. Am J Ophthalmol 2014; 157(1): 56–62, https://doi.org/10.1016/j.ajo.2013.08.032.
78. Barash A., Chou T.Y. Moraxella atlantae keratitis presenting with an infectious ring ulcer. Am J Ophthalmol Case Rep 2017; 7: 62–65, https://doi.org/10.1016/j.ajoc.2017.06.003.
79. Thomas P.A. Fungal infections of the cornea. Eye (Lond) 2003; 17(8): 852–862, https://doi.org/10.1038/sj.eye.6700557.
80. Arzhimatova G.S., Obrubov A.S. Urgent keratoplasty in fungal keratitis. Sovremennye tehnologii v oftal’mologii 2021; 4: 43–45, https://doi.org/10.25276/2312-4911-2021-4-43-45.
81. Krichevskaya G.I., Kovaleva L.A., Zyurnyayeva I.D., Makarov P.V., Andryushin A.E. The effectiveness of PCR in diagnosis of fungal keratitis. Oftal’mologia 2020; 17(4): 824–829, https://doi.org/10.18008/1816-5095-2020-4-824-829.
82. Ansari Z., Miller D., Galor A. Current thoughts in fungal keratitis: diagnosis and treatment. Curr Fungal Infect Rep 2013; 7(3): 209–218.
83. Ren Z., Liu Q., Wang Y., Dong Y., Huang Y. Diagnostic information profiling and evaluation of causative fungi of fungal keratitis using high-throughput internal transcribed spacer sequencing. Sci Rep 2020; 10(1): 1640, https://doi.org/10.1038/s41598-020-58245-7.
84. Deorukhkar S., Katiyar R., Saini S. Epidemiological features and laboratory results of bacterial and fungal keratitis: a five-year study a rural tertiary-care hospital in western Maharashtra, India. Singapore Med J 2012; 53(4): 264–267.
85. Raj N., Vanathi M., Ahmed N.H., Gupta N., Lomi N., Tandon R. Recent perspectives in the management of fungal keratitis. J Fungi (Basel) 2021; 7(11): 907, https://doi.org/10.3390/jof7110907.
86. Ray K.J., Lalitha P., Prajna N.V., Rajaraman R., Krishnan T., Srinivasan M., Ryg P., McLeod S., Acharya N.R., Lietman T.M., Rose-Nussbaumer J.; Mycotic Ulcer Treatment Trial Group. The utility of repeat culture in fungal corneal ulcer management: a secondary analysis of the MUTT-I randomized clinical trial. Am J Ophthalmol 2017; 178: 157–162, https://doi.org/10.1016/j.ajo.2017.03.032.
87. Belskaia K.I., Obrubov A.S. Non-cultural diagnostic methods of fungal keratitis. Russkij medicinskij zurnal. Kliniceskaa oftal’mologia 2018; 19(1): 37–41, https://doi.org/10.21689/2311-7729-2018-18-1-37-41.
88. Sharma S., Kunimoto D.Y., Gopinathan U., Athmanathan S., Garg P., Rao G.N. Evaluation of corneal scraping smear examination methods in the diagnosis of bacterial and fungal keratitis: a survey of eight years of laboratory experience. Cornea 2002; 21(7): 643–647, https://doi.org/10.1097/00003226-200210000-00002.
89. Bakken I.M., Jackson C.J., Utheim T.P., Villani E., Hamrah P., Kheirkhah A., Nielsen E., Hau S., Lagali N.S. The use of in vivo confocal microscopy in fungal keratitis — progress and challenges. Ocul Surf 2022; 24: 103–118, https://doi.org/10.1016/j.jtos.2022.03.002.
90. Tabatabaei S.A., Soleimani M., Tabatabaei S.M., Beheshtnejad A.H., Valipour N., Mahmoudi S. The use of in vivo confocal microscopy to track treatment success in fungal keratitis and to differentiate between Fusarium and Aspergillus keratitis. Int Ophthalmol 2020; 40(2): 483–491, https://doi.org/10.1007/s10792-019-01209-2.
91. Hoffman J.J., Dart J.K.G., De S.K., Carnt N., Cleary G., Hau S. Comparison of culture, confocal microscopy and PCR in routine hospital use for microbial keratitis diagnosis. Eye (Lond) 2022; 36(11): 2172–2178, https://doi.org/10.1038/s41433-021-01812-7.
92. Hau S.C., Dart J.K., Vesaluoma M., Parmar D.N., Claerhout I., Bibi K., Larkin D.F. Diagnostic accuracy of microbial keratitis with in vivo scanning laser confocal microscopy. Br J Ophthalmol 2010; 94(8): 982–987, https://doi.org/10.1136/bjo.2009.175083.
93. Kheirkhah A., Syed Z.A., Satitpitakul V., Goyal S., Müller R., Tu E.Y., Dana R. Sensitivity and specificity of laser-scanning in vivo confocal microscopy for filamentous fungal keratitis: role of observer experience. Am J Ophthalmol 2017; 179: 81–89, https://doi.org/10.1016/j.ajo.2017.04.011.
94. Wang Y.E., Tepelus T.C., Vickers L.A., Baghdasaryan E., Gui W., Huang P., Irvine J.A., Sadda S., Hsu H.Y., Lee O.L. Role of in vivo confocal microscopy in the diagnosis of infectious keratitis. Int Ophthalmol 2019; 39(12): 2865–2874, https://doi.org/10.1007/s10792-019-01134-4.
95. Pashtaev N.P., Kulikova I.L., Shlenskaya O.V., Volkova L.N. Confocal microscopy of cornea in keratorefractive surgery. Review. Vestnik rossijskih universitetov. Matematika 2015; 20(3): 662–666.
96. Soliman W., Fathalla A.M., El-Sebaity D.M., Al-Hussaini A.K. Spectral domain anterior segment optical coherence tomography in microbial keratitis. Graefes Arch Clin Exp Ophthalmol 2013; 251(2): 549–553, https://doi.org/10.1007/s00417-012-2086-5.
97. Behera H.S., Srigyan D. Evaluation of polymerase chain reaction over routine microbial diagnosis for the diagnosis of fungal keratitis. Optom Vis Sci 2021; 98(3): 280–284, https://doi.org/10.1097/opx.0000000000001652.
98. Pouyeh B., Galor A., Miller D., Alfonso E.C. New horizons in one of ophthalmology’s challenges: fungal keratitis. Expert Rev Ophthalmol 2011; 6(5): 529–540, https://doi.org/10.1586/eop.11.58.
99. Shigeyasu C., Yamada M., Aoki K., Ishii Y., Tateda K., Yaguchi T., Okajima Y., Hori Y. Metagenomic analysis for detecting Fusarium solani in a case of fungal keratitis. J Infect Chemother 2018; 24(8): 664–668, https://doi.org/10.1016/j.jiac.2017.12.019.
100. Lalitha P., Prajna N.V., Sikha M., Gunasekaran R., Hinterwirth A., Worden L., Chen C., Zhong L., Liu Z., Lietman T.M., Seitzman G.D., Doan T. Evaluation of metagenomic deep sequencing as a diagnostic test for infectious keratitis. Ophthalmology 2021; 128(3): 473–475, https://doi.org/10.1016/j.ophtha.2020.07.030.
101. Ananthi S., Chitra T., Bini R., Prajna N.V., Lalitha P., Dharmalingam K. Comparative analysis of the tear protein profile in mycotic keratitis patients. Mol Vis 2008; 14: 500–507.
102. Zhao G., Zhai H., Yuan Q., Sun S., Liu T., Xie L. Rapid and sensitive diagnosis of fungal keratitis with direct PCR without template DNA extraction. Clin Microbiol Infect 2014; 20(10): O776–O782, https://doi.org/10.1093/mmy/myx125.
103. Lee M.H., Wiedman G., Park S., Mustaev A., Zhao Y., Perlin D.S. A novel, tomographic imaging probe for rapid diagnosis of fungal keratitis. Med Mycol 2018; 56(7): 796–802, https://doi.org/10.1093/mmy/myx125.
104. Ivanova L.V., Barantsevich E.P., Shlyakchto E.V. Resistance of fungi-pathogens to antifungal preparations (review). Problemy medicinskoj mikologii 2011; 13(1): 14–17.
105. Samoylov A.N., Davletshina N.I. Analysis of etiology and antimicrobial sensitivity of fungal keratitis pathogens in a series of clinical cases. Oftal’mohirurgia 2020; 1: 71–76, https://doi.org/10.25276/0235-4160-2020-1-71-76.

Sitnova A.V., Svetozarskiy S.N. Modern Technologies in Diagnosis of Fungal Keratitis (Review). Sovremennye tehnologii v medicine 2023; 15(2): 73, https://doi.org/10.17691/stm2023.15.2.07